Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	177.99	75.62	-	-	-	-	Upgrade
Cost of Revenue	121.44	112.86	103.37	-	-	-	Upgrade
Gross Profit	56.55	-37.24	-103.37	-	-	-	Upgrade
Selling, General & Admin	41.59	43.87	39.94	35.12	15.73	4.01	Upgrade
Research & Development	-	-	-	77.26	57.16	24.01	Upgrade
Operating Expenses	41.59	43.87	39.94	112.38	72.88	28.01	Upgrade
Operating Income	14.96	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
Interest & Investment Income	11.99	10.57	9.33	3.76	0.05	0.01	Upgrade
Currency Exchange Gain (Loss)	1.41	0.42	-0.93	0.01	-0.16	-0.2	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	-0.96	-7.68	Upgrade
EBT Excluding Unusual Items	28.37	-70.13	-134.91	-108.61	-73.96	-35.88	Upgrade
Gain (Loss) on Sale of Investments	-	-	-0.13	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	0.06	-	0.02	0.11	-	-	Upgrade
Pretax Income	28.42	-70.13	-135.01	-108.5	-73.96	-35.88	Upgrade
Income Tax Expense	4.26	2.57	0.34	-	-	-	Upgrade
Net Income	24.17	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Net Income to Common	24.17	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Shares Outstanding (Basic)	82	74	51	47	25	2	Upgrade
Shares Outstanding (Diluted)	83	74	51	47	25	2	Upgrade
Shares Change (YoY)	38.55%	43.80%	8.83%	88.91%	1548.09%	7.11%	Upgrade
EPS (Basic)	0.29	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
EPS (Diluted)	0.29	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
Free Cash Flow	23.85	38.01	-62.84	-105.38	-69.1	-26.44	Upgrade
Free Cash Flow Per Share	0.29	0.51	-1.22	-2.23	-2.76	-17.43	Upgrade
Gross Margin	31.77%	-49.25%	-	-	-	-	Upgrade
Operating Margin	8.40%	-107.26%	-	-	-	-	Upgrade
Profit Margin	13.58%	-96.14%	-	-	-	-	Upgrade
Free Cash Flow Margin	13.40%	50.26%	-	-	-	-	Upgrade
EBITDA	23.3	-72.99	-137.09	-108.64	-70.75	-27.47	Upgrade
EBITDA Margin	13.09%	-96.52%	-	-	-	-	Upgrade
D&A For EBITDA	8.34	8.12	6.22	3.75	2.13	0.54	Upgrade
EBIT	14.96	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
EBIT Margin	8.40%	-107.26%	-	-	-	-	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q